Filing Flows › Comparisons › GYRE vs ELTP
Gyre Therapeutics vs Elite Pharmaceuticals: GYRE and ELTP compared
Gyre Therapeutics is the larger company: $32.9M of revenue in its latest quarter (Q3 2026) against $32.4M for Elite Pharmaceuticals (Q1 FY27). Gyre Therapeutics is growing faster (+0.7% against -20% a year earlier). Elite Pharmaceuticals is more profitable, with an operating margin of 23.3% against -4.6%.
Where the money goes: GYRE and ELTP
Gyre Therapeutics (GYRE) · Q3 2026
Gyre Therapeutics, Q3 2026: revenue $32.9M (+0.7% year over year), operating margin -4.6%, net loss $2.5M, operating cash flow −$4.0M. The chart follows the revenue to costs, profit and cash.
Elite Pharmaceuticals (ELTP) · Q1 FY27
Elite Pharmaceuticals, Q1 FY27: revenue $32.4M (-20% year over year), operating margin 23.3%, net earnings $5.9M, operating cash flow $10.1M. The chart follows the revenue to costs, profit and cash.
| Gyre Therapeutics (GYRE) | Elite Pharmaceuticals (ELTP) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q1 FY27 |
| Revenue | $32.9M | $32.4M |
| Revenue growth, Y/Y | +0.7% | -20% |
| Gross margin | — | 41.7% |
| Operating margin | -4.6% | 23.3% |
| Net earnings | −$2.5M | $5.9M |
| Net margin | -7.5% | 18.3% |
| Operating cash flow | −$4.0M | $10.1M |
| Free cash flow | — | $9.3M |
Where the revenue comes from
Gyre Therapeutics
- Gyre Pharmaceuticals: $32.4M (98%)
- Gyre: $508K (2%)
Elite Pharmaceuticals
- Abbreviated New Drug Applications Revenue: $32.1M (99%)
- Licensing: $221K (1%)
Questions
Which is bigger, Gyre Therapeutics or Elite Pharmaceuticals?
Gyre Therapeutics is the larger company: $32.9M of revenue in its latest quarter (Q3 2026) against $32.4M for Elite Pharmaceuticals (Q1 FY27).
Is Gyre Therapeutics or Elite Pharmaceuticals growing faster?
Gyre Therapeutics is growing faster (+0.7% against -20% a year earlier).
Which is more profitable, Gyre Therapeutics or Elite Pharmaceuticals?
Elite Pharmaceuticals is more profitable, with an operating margin of 23.3% against -4.6%.
More: Gyre Therapeutics earnings · how Gyre Therapeutics makes money · Elite Pharmaceuticals earnings · how Elite Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 6, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.